UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Choosing a retirement plan over a 401k can be beneficial in specific situations. Discover when to make this important choice.
25,535 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
HYPE breaks above $57 as a short squeeze pushes the token within 2% of its all-time high, with negative funding and s...
Parsons Corp faces a tough mix: a record backlog rising margins boost profitability, yet an upcoming policy and contr...
Broadcom faces a fast-changing AI compute cycle that could lift shares toward $630, backed by custom silicon demand a...
A memory-focused rally has vaulted a mid-cap equipment maker by about 90% in 2.5 months, shifting attention away from...
A podcast recap attributes a Bezos stance to exempting the bottom half from federal income taxes, highlighting a broa...
Dogecoin trades around $0.096 after a weekly drop, with analysts pointing to a TD Sequential buy signal and key suppo...
Bitcoin’s $63k slide shows ETF demand clashing with AI-driven stock rallies for scarce dollar liquidity, reshaping cr...
Bitcoin steadies near $60,000 as Pi Network’s PI token rebounds after hitting a new all-time low. Weekend liquidity a...
Oracle enters a critical earnings season with eyes on its AI pivot and data-center expansion. The market has piled on...
Ford famously pulled back from most sedans years ago. This article examines the strategic pivot, what a sedan comebac...
America is racing to rebuild its nuclear fuel chain as the next generation of reactors edges toward reality. The move...